Town Hall – CAPTURE Study
September 2, 2015
2015 ASK THE EXPERT PODCAST SERIES SPONSORED BY
Chugai Pharmaceutical Co, Ltd is conducting clinical studies to create original and innovative drugs, both in the USA and overseas, to address unmet medical needs in neurological disorders, where the level of pharmaceutical contribution and satisfaction concerning patient treatment remains low.
* The Executive Committee of SRNA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal to deliver medical breakthroughs where none currently exist is driven by the knowledge that people’s lives depend on their work.
* The Executive Committee of SRNA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.
LISTEN & SUBSCRIBE ON ITUNES
DOWNLOAD MP3
About Our Guest Speakers
Benjamin M. Greenberg, MD, MHS
Associate Professor at UT Southwestern Medical Center, Director of the Transverse Myelitis and Neuromyelitis Optica Program, Dallas, TX
Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system. He splits his clinical time between seeing both adult and pediatric patients. He routinely consults on the inpatient units of Zale-Lipshy University Hospital, Parkland Memorial Hospital, and Children’s Health. His research interests are in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis, multiples sclerosis, and infections of the nervous system. He is actively involved in developing better ways to diagnose and prognosticate for patients with these disorders. He has led an effort to improve biorepository development and has created uniform protocols for sample handling and analysis. As part of this initiative his research has identified novel biomarkers that may be able to distinguish between patients with various neurologic disorders. He also coordinates trials that study new treatments to prevent neurologic damage and restore function to those who have already been affected. He currently serves as the Director of the Neurosciences Clinical Research Center at UT Southwestern and is a Cain-Denius Foundation Scholar. Dr. Greenberg is a member of The Board of Directors of The Siegel Rare Neuroimmune Association and also Chairs SRNA Medical and Scientific Council.
Brenda L. Banwell, MD
Professor of Neurology at The Children’s Hospital of Philadelphia
Dr. Banwell graduated with a degree in medicine from The University of Western Ontario in 1991. She pursued a residency in pediatrics at The Hospital of Western Ontario, University of Western Ontario, from 1991-1994 and a pediatric neurology residency at The Hospital for Sick Children, University of Toronto from 1994-1997. Dr. Banwell then spent two years completing a neuromuscular disease fellowship at the Mayo Clinic, Rochester, Minnesota. In 1999, Dr. Banwell was appointed as an assistant professor of paediatrics (neurology) at the Hospital for Sick Children and University of Toronto. She was promoted to associate professor in 2006 and full professor in 2012. As of July 1, 2012, Dr. Banwell has taken on the role of chief of neurology at The Children’s Hospital of Philadelphia.
Dr. Banwell’s clinical and research interests are in pediatric multiple sclerosis and other inflammatory brain disorders. She remains the lead investigator of the Canadian Pediatric Demyelinating Disease Program, which has now partnered with the pediatric demyelinating disease program in Philadelphia. Here at CHOP, Dr. Banwell is the director of the Pediatric Multiple Sclerosis Clinic, a multidisciplinary clinic dedicated to children with multiple sclerosis and other acquired demyelinating diseases. Her clinical studies focus on the cognitive and neuroimaging features of pediatric multiple sclerosis, while the basic science work focuses on T and B-cell autoimmunity studies, MRI imaging, and studies of viral triggers. Dr. Banwell is the principal investigator of a 23 site, eight year study of acute demyelination in children from every pediatric health care facility in Canada and now CHOP (funded by the Canadian Multiple Sclerosis Research Foundation and CHOP). She holds CIHR Investigator Grants, operating grants from the Canadian Multiple Sclerosis Society, and has been successfully funded for over 12 years. Dr. Banwell has more than 100 manuscripts published in high impact journals (including JAMA, Lancet Neurology and Nature Medicine), as well as 11 book chapters. She has over 100 invited lectureships or visiting Professorships in Canada, the United States and Europe.
Sarah Hopkins, MD, MSPH
Pediatric neurologist at The Children’s Hospital of Philadelphia
Sarah Hopkins, MD, MSPH, is a pediatric neurologist at The Children’s Hospital of Philadelphia. She is an Assistant Professor of Clinical Neurology, Perelman School of Medicine at the University of Pennsylvania. She sees patients in the Pediatric Multiple Sclerosis Clinic at CHOP, and has an interest in transverse myelitis. She completed her medical school at University of Arkansas in Little Rock, AR, her pediatric residency and Fellowship in Child Neurology at Cincinnati Children’s Hospital Medical Center, Cincinnati, OH. Dr. Hopkins also has a graduate degree (MSPH) in Epidemiology from The Rollins School of Public Health, Emory University, Atlanta, GA.
